Senior / Principal Scientist, ADC Conjugation Process Development

Reposted 17 Hours Ago
Be an Early Applicant
Bothell, WA, USA
In-Office
146K-188K Annually
Senior level
Biotech • Pharmaceutical
The Role
Lead ADC conjugation process development from milligram to multi-gram (>100 g) scale, optimizing conjugation and purification (TFF/UF-DF, chromatography), executing DOE/OFAT studies, coordinating tech transfers and CDMO partnerships, preparing GMP documentation and regulatory module 3 materials, and supporting IND/BLA activities and GLP tox studies while advising cross-functional teams.
Summary Generated by Built In

Company Overview

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been submitted to the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-3050, an IND-cleared FAP-targeted radiotherapy; and IM-1617, an IND-cleared solid tumor ADC. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

We are seeking an experienced and motivated Senior/Principal Scientist in ADC Conjugation Process Development to support our growing pipeline. This role will be responsible for the optimization of critical conjugation and purification process parameters for ADC Drug Substance (DS) Development. The preferred candidate will coordinate and execute strategies from milligram to multi-gram scales, including tox/GMP batches, while demonstrating practical expertise in different methodologies and purification strategies for clinical and commercial-stage ADC DS manufacturing. The ideal candidate will have experience with technology transfer, regulatory compliance, and coordination with CDMO partners at GMP manufacturing facilities. A strong working knowledge of different conjugation technologies and cytotoxic linker-payloads is essential, as is experience with standard analytical and characterization approaches used for both biologics and ADCs.   

Responsibilities

  • Implement and execute ADC Conjugation Process Development (PD) strategies, including Design of Experiment (DOE) and One Factor at a Time (OFAT) approaches for critical reaction parameters.  
  • Oversee the progression of ADC batch sizes from milligram to >100 g scales to support not only PD optimization, but analytical and formulation development, DS/DP stability studies, and in vivo experiments (including critical GLP tox studies) for both IND- and BLA-stage activities.   
  • Lead the multi-gram scale purification optimization for both antibody intermediates and ADCs via ultrafiltration/diafiltration (UF/DF), and, if required, preparative chromatography or other approaches.  
  • Fulfill role as ADC DS subject matter expert (SME) on both internal cross-functional CMC teams and for external CDMO partners to ensure alignment on ADC program goals, deliverables, and objectives. Occasional travel to advise and oversee Development and GMP manufacturing processes will be expected.  
  • Prepare essential documentation (SOPs, protocols, and reports) to support tech transfers, GMP activities, and regulatory submissions for clinical development and commercialization.  
  • Stay current with emerging trends, innovations, and regulatory requirements for ADC DS, integrating necessary or potentially beneficial features into our internal company strategies and workflows.  
  • Lead/support authoring and reviewing of relevant module 3 sections of regulatory submissions (IND, IMPD, BLA, etc.), along with, if necessary, responding to information requests and interfacing with global health authorities.  

  

Qualifications

  • A Bachelors, Masters, or Ph.D. degree in Chemistry, Chemical/Biochemical Engineering, Biotechnology, or a related field.  
  • A minimum of 5 years of biotech/biopharma industry experience with a Ph.D., 8 years with a Master’s, or 10 years with a Bachelor’s degree, or equivalent experience. An ADC or Conjugation/Bioconjugation Process Development focus is required 
  • Demonstrated success with the development and scale-up of different ADC conjugation technologies and strategies, including a proven ability to work with a variety of different small molecule linker-payloads and antibody intermediate materials. Expected expertise in relevant laboratory operations and equipment necessary for successful execution of development activities.  
  • Prior experience with tech transfer, external CDMO engagement (encompassing both Development and GMP manufacturing activities), and internal coordination with relevant cross-functional teams.  

  

Knowledge and Skills

  • A strong understanding of the common conjugation, purification, analytical, and characterization approaches used for ADCs, with a solid foundation in overcoming some of the challenges encountered in these workflows.   
  • Expertise in tangential flow filtration (TFF) at the multi-gram scale for the efficient removal of unreacted linker-payloads and to provide a stable ADC DS formulation.    
  • Good working knowledge of standard analytical and characterization techniques used for ADCs including, but not limited to, SEC, HIC, and RP U/HPLC chromatographic methods in addition to LC-MS, icIEF, and CE-SDS strategies for biomolecules and related conjugates.  
  • Knowledge of GMP standards and regulatory guidelines, with experience supporting IND, INDa, and BLA submissions.  
  • The ability to manage multiple projects simultaneously while being able to prioritize and balance hands-on tasks with strategic responsibilities.  
  • Exceptional communication skills, with an emphasis on effective collaborations with both internal stakeholders and external partners. 

 

Washington State Pay Range
$146,000$188,000 USD

E/E/O

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

E-Verify

Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).

Skills Required

  • Bachelor's, Master's, or Ph.D. in Chemistry, Chemical/Biochemical Engineering, Biotechnology, or related field
  • Minimum industry experience: 5 years (Ph.D.), 8 years (Master's), or 10 years (Bachelor's) in biotech/pharma
  • Demonstrated ADC or Conjugation/Bioconjugation Process Development focus
  • Proven experience developing and scaling diverse ADC conjugation technologies and working with various linker-payloads and antibody intermediates
  • Expertise in tangential flow filtration (TFF) and ultrafiltration/diafiltration (UF/DF) at multi-gram scale
  • Experience with preparative chromatography and multi-gram purification optimization
  • Working knowledge of analytical methods: SEC, HIC, RP U/HPLC, LC-MS, icIEF, CE-SDS
  • Experience with tech transfer and engagement with external CDMOs for Development and GMP manufacturing
  • Knowledge of GMP standards and experience supporting IND, INDa, and BLA submissions
  • Ability to prepare SOPs, protocols, reports, and author/review regulatory Module 3 content
  • Ability to manage multiple projects, prioritize tasks, and collaborate cross-functionally with strong communication skills
  • Willingness/ability to travel occasionally to advise and oversee development and GMP manufacturing processes
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Bothell, Washington
180 Employees

What We Do

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Similar Jobs

CoreWeave Logo CoreWeave

Technical Program Manager

Cloud • Information Technology • Machine Learning
In-Office
5 Locations
1450 Employees
177K-237K Annually

CoreWeave Logo CoreWeave

Senior Software Engineer

Cloud • Information Technology • Machine Learning
In-Office
5 Locations
1450 Employees
153K-204K Annually

Eve Logo Eve

Customer Success Manager

Legal Tech • Software • Generative AI
Easy Apply
Remote or Hybrid
United States
180 Employees
150K-190K Annually

Snap Inc. Logo Snap Inc.

Manager, Client Partner

Artificial Intelligence • Cloud • Machine Learning • Mobile • Software • Virtual Reality • App development
Hybrid
4 Locations
5000 Employees
195K-343K Annually

Similar Companies Hiring

SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees
Cencora Thumbnail
Healthtech • Logistics • Pharmaceutical
Conshohocken, PA
51000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account